ArticleCancer research communications2023

A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors.

Glenn J Hanna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.